Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 118,653 shares at $51.26 ($6.0M) on 2018-05-07, disclosed to the SEC on 2018-05-09.
Open-market sale of $6.0M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.31 | 2,862 | $144K | 2.4% |
| 2 | $50.31 | 3,172 | $160K | 2.7% |
| 3 | $50.31 | 7,424 | $374K | 6.2% |
| 4 | $50.31 | 97,550 | $4.9M | 82.1% |
| 5 | $51.26 | 7,645 | $392K | 6.6% |
| Total | $50.37 avg | 118,653 |
| $6.0M |
| 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |